Pillstats
Rx only · Tablet · Oral

Anastrozole Tablets

Brands: Anastrozole · Anastrozole

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)84857
US makers6 labelers
Packages14
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.042$0.084$0.126$0.168Dec 2025Apr 2026Jul 2026
$0.136
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
6
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.7K13K20K27K2025 Q12025 Q22025 Q32025 Q42026 Q1
18K
Rx · 2026 Q1
648K
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Asclemed USA, Inc.unknown4SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown3SUPPLYING
Proficient Rx LPunknown2SUPPLYING
Upsher-Smith Laboratories, LLCunknown2SUPPLYING
Yiling Pharmaceutical Inc.unknown2SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.